Jeffrey Boone Miller
Overview
Explore the profile of Jeffrey Boone Miller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
500
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Beermann M, Homma S, Miller J
BMC Res Notes
. 2022 May;
15(1):163.
PMID: 35538497
Objective: Aberrant expression in skeletal muscle of DUX4, a double homeobox transcription factor, underlies pathogenesis in facioscapulohumeral muscular dystrophy (FSHD). Although previous studies of FSHD muscle biopsies detected mRNAs encoding...
2.
Masteika I, Sathya A, Homma S, Miller B, Boyce F, Miller J
Biol Open
. 2022 Feb;
11(2).
PMID: 35191484
Abnormal expression in skeletal muscle of the double homeobox transcription factor DUX4 underlies pathogenesis in facioscapulohumeral muscular dystrophy (FSHD). Though multiple changes are known to be initiated by aberrant DUX4...
3.
Mitsuhashi H, Homma S, Beermann M, Ishimaru S, Takeda H, Yu B, et al.
Sci Rep
. 2019 Feb;
9(1):2274.
PMID: 30783185
We present a plasmid-based system in which upstream trans-splicing efficiently generates mRNAs that encode head-to-tail protein multimers. In this system, trans-splicing occurs between one of two downstream splice donors in...
4.
Mitsuhashi H, Ishimaru S, Homma S, Yu B, Honma Y, Beermann M, et al.
Biol Open
. 2018 Apr;
7(4).
PMID: 29618456
Aberrant expression of the full-length isoform of DUX4 (DUX4-FL) appears to underlie pathogenesis in facioscapulohumeral muscular dystrophy (FSHD). DUX4-FL is a transcription factor and ectopic expression of DUX4-FL is toxic...
5.
Yoon S, Beermann M, Yu B, Shao D, Bachschmid M, Miller J
J Neuromuscul Dis
. 2017 Dec;
5(1):59-73.
PMID: 29278895
Background: Mutations in the LAMA2 gene encoding laminin-α2 cause congenital muscular dystrophy Type 1A (MDC1A), a severe recessive disease with no effective treatment. Previous studies have shown that aberrant activation...
6.
Homma S, Beermann M, Yu B, Boyce F, Miller J
Skelet Muscle
. 2016 Dec;
6(1):42.
PMID: 27906075
Background: Nuclear bodies, such as nucleoli, PML bodies, and SC35 speckles, are dynamic sub-nuclear structures that regulate multiple genetic and epigenetic processes. Additional regulation is provided by RNA/DNA handling proteins,...
7.
Homma S, Beermann M, Boyce F, Miller J
Ann Clin Transl Neurol
. 2015 Mar;
2(2):151-66.
PMID: 25750920
Objective: Pathogenesis in facioscapulohumeral muscular dystrophy (FSHD) appears to be due to aberrant expression, particularly in skeletal muscle nuclei, of the full-length isoform of DUX4 (DUX4-FL). Expression of DUX4-FL is...
8.
Yoon S, Stadler G, Beermann M, Schmidt E, Windelborn J, Schneiderat P, et al.
Skelet Muscle
. 2013 Dec;
3(1):28.
PMID: 24314268
Background: Congenital muscular dystrophy Type 1A (MDC1A) is a severe, recessive disease of childhood onset that is caused by mutations in the LAMA2 gene encoding laminin-α2. Studies with both mouse...
9.
Homma S, Chen J, Rahimov F, Beermann M, Hanger K, Bibat G, et al.
Eur J Hum Genet
. 2011 Nov;
20(4):404-10.
PMID: 22108603
To explore possible mechanisms of pathology in facioscapulohumeral muscular dystrophy (FSHD), we generated a novel library of myogenic cells composed of paired cultures derived from FSHD subjects and unaffected first-degree...
10.
Homma S, Beermann M, Miller J
Hum Mol Genet
. 2011 Apr;
20(13):2662-72.
PMID: 21505075
The most common form of childhood congenital muscular dystrophy, Type 1A (MDC1A), is caused by mutations in the human LAMA2 gene that encodes the laminin-α2 subunit. In addition to skeletal...